Authors: Crombet, T Torres, O Neninger, E Catala, M Rodriguez, N Ramos, M Fernandez, E Iznaga, N Perez, R Lage, A

Citation: T. Crombet et al., Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor, CANC BIO R, 16(1), 2001, pp. 93-102

Authors: Crombet, T Torres, O Rodriguez, V Menendez, A Stevenson, A Ramos, M Torres, F Figueredo, R Veitia, I Iznaga, N Perez, R Lage, A

Citation: T. Crombet et al., Phase I clinical evaluation of a neutralizing monoclonal antibody against epidermal growth factor receptor in advanced brain tumor patients: Preliminary study, HYBRIDOMA, 20(2), 2001, pp. 131-136

Authors: Leon, K Perez, R Lage, A Carneiro, J

Citation: K. Leon et al., Three-cell interactions in T cell-mediated suppression? A mathematical analysis of its quantitative implications, J IMMUNOL, 166(9), 2001, pp. 5356-5365

Authors: Montero, E Amador, JF Perez, R Lage, A

Citation: E. Montero et al., Tumor-specific immunotherapy based on dominant models of natural tolerance, MED HYPOTH, 54(4), 2000, pp. 531-536

Authors: Leon, K Perez, R Lage, A Carneiro, J

Citation: K. Leon et al., Modelling T-cell-mediated suppression dependent on interactions in multicellular conjugates, J THEOR BIO, 207(2), 2000, pp. 231-254

Authors: Macias, A Arce, S Leon, J Mustelier, G Bombino, G Domarco, A Perez, R Lage, A

Citation: A. Macias et al., Novel cross-reactive anti-idiotype antibodies with properties close to thehuman intravenous immunoglobulin (IVIg), HYBRIDOMA, 18(3), 1999, pp. 263-272